Queiroz Marjorie F N, Ferreira Felipe Q T, Shimoda Gilberto, Padovani Carlos Roberto, Lottelli Antonio C
Division of Ophthalmology, Surgical Specialties and Anesthesiology Department, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista "Júlio de Mesquita Filho, Botucatu, SP, Brazil.
Centro de Microcirurgia Ocular Atibaia, Atibaia, SP, Brazil.
Arq Bras Oftalmol. 2023 Jul-Aug;86(4):301-307. doi: 10.5935/0004-2749.20230054.
To evaluate visual outcomes, satisfaction, and quality of life of patients assisted in a Medical School hospital by the Brazilian Public Health System, who underwent bilateral diffractive multifocal intraocular lens implantation.
Case series study with intervention, including 20 patients who underwent bilateral implantation of multifocal IOL EyeDiff® (Eyeol UK, Dunstable, UK). Exclusion criteria were corneal astigmatism >1.5 cylindrical diopters, previous ocular surgery or ocular disease, and intra- or postoperative complications. Patients were evaluated one, three, and six months after surgery. Monocular and binocular visual acuity for distance, intermediate and near, under photopic and mesopic conditions, monocular contrast sensitivity under photopic conditions, defocus curve, and quality of life were assessed.
Monocular distance-corrected visual acuity was 0.3 logMAR or better and monocular distance-corrected near visual acuity was J3 or better in all eyes under photopic conditions. Binocular distance-corrected near visual acuity was J1 in all cases. Contrast sensitivity was at the minimum level of normality for low and high spatial frequencies and within normal limits for intermediate spatial frequency. The quality of life questionnaire showed a high level of patient satisfaction.
Bilateral implantation of the multifocal intraocular lens EyeDiff® provides patients with good visual acuity and quality of life, besides spectacle independence. The visual acuity and contrast sensitivity progressively improved between one and six postoperative months.
评估在巴西公共卫生系统资助下，于一所医学院附属医院接受双眼衍射多焦点人工晶状体植入手术的患者的视觉效果、满意度和生活质量。
采用干预性病例系列研究，纳入20例接受双眼EyeDiff®多焦点人工晶状体（英国邓斯特布尔Eyeol公司）植入手术的患者。排除标准为角膜散光＞1.5圆柱镜度、既往眼部手术史或眼部疾病以及术中或术后并发症。在术后1个月、3个月和6个月对患者进行评估。评估了明视和中视条件下的单眼及双眼远、中、近视力，明视条件下单眼对比敏感度、散焦曲线和生活质量。
在明视条件下，所有术眼的单眼矫正远视力均为0.3 logMAR或更好，单眼矫正近视力均为J3或更好。所有病例的双眼矫正近视力均为J1。低空间频率和高空间频率的对比敏感度处于正常最低水平，中空间频率的对比敏感度在正常范围内。生活质量问卷显示患者满意度较高。
双眼植入EyeDiff®多焦点人工晶状体除了使患者无需佩戴眼镜外，还为其提供了良好的视力和生活质量。术后1至6个月，视力和对比敏感度逐渐改善。
